This study evaluates the experience of musicians who are going through cancer treatment.
Additional locations may be listed on ClinicalTrials.gov for NCT06494046.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVES:
I. Describe specific musical difficulties that arise during and after cancer treatments: define "musical toxicity".
II. Discover any interventions or treatments which musicians found helpful while going through cancer treatment.
III. Investigate whether the priority of playing music changed through the course of cancer treatment and beyond, in relation to other priorities including cancer cure and length of life.
IV. Discover treatment and cancer related factors which are correlated with worse musical toxicity.
OUTLINE: This is an observational study. Patients are assigned to 1 of 2 groups.
MUSICAL TOXICITY GROUP: Patients complete a questionnaire, participate in an interview and have their medical records reviewed on study.
NO MUSICAL TOXICITY GROUP: Patients have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationMayo Clinic in Rochester
Principal InvestigatorDean A. Shumway